Description: Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France. Euroapi SA operates as a subsidiary of Sanofi.
Home Page: www.euroapi.com/en
15 Rue Traversiere
Paris,
75012
France
Phone:
33 1 89 20 62 00
Officers
| Name | Title |
|---|---|
| Mr. Ludwig De Mot | CEO, Executive VP & Chief Transformation Officer |
| Mr. Olivier Falut | Chief Financial Officer |
| Mr. David Seignolle | Chief Operating Officer |
| Mr. Kai Rossen | Chief Scientific Officer |
| Sophie Palliez | Head of Investor Relations |
| Ms. Marion Santin | Chief Legal, Compliance, & IP Officer |
| Ute Herzog | Chief Human Resources Officer |
| Ms. Cecile Maupas | Chief CDMO (Contract Development and Manufacturing Organization) Officer |
| Mr. Vincent Touraille | Chief Strategy and M&A Officer |
| Mr. Bruno Laforge | Chief Corporate Affairs Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 27.6243 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3415 |
| Price-to-Sales TTM: | 0.3967 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3650 |